MedPath

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes

Phase 3
Not yet recruiting
Conditions
Obesity
Overweight
Type 2 Diabetes
Interventions
Drug: Placebo
Registration Number
NCT06972472
Lead Sponsor
Eli Lilly and Company
Brief Summary

The main purpose of this study is to see how orforglipron, compared with placebo, helps improve glycemic control in participants with obesity or with overweight and type 2 diabetes. This trial is part of the master protocol study J2A-MC-GZPO.

Participation in the study will last about 18 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
600
Inclusion Criteria
  • Have body mass index (BMI) ≥25 kilograms per square meter (kg/m2) at screening
  • Have type 2 diabetes
  • Have hemoglobin A1c (HbA1c) ≥7% and ≤10% at screening
  • Have a history of at least one unsuccessful dietary effort to lose body weight
Exclusion Criteria
  • Have type 1 diabetes
  • Have an unstable body weight within 90 days prior to screening
  • Have New York Heart Association functional classification IV congestive heart failure or an acute cardiovascular condition within 90 days prior to screening
  • Have acute or chronic hepatitis or pancreatitis
  • Are taking other medications or alternative remedies to manage weight loss

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Orforglipron Dose 1OrforglipronParticipants will receive orforglipron orally
Orforglipron Dose 2OrforglipronParticipants will receive orforglipron orally
Orforglipron Dose 3OrforglipronParticipants will receive orforglipron orally
Orforglipron Dose 4OrforglipronParticipants will receive orforglipron orally
PlaceboPlaceboParticipants will receive placebo orally
Primary Outcome Measures
NameTimeMethod
Change from Baseline in Hemoglobin A1c (HbA1c)Baseline, Week 40
Secondary Outcome Measures
NameTimeMethod
Percent Change from Baseline in Body WeightBaseline up to 72 weeks
Change from Baseline in HbA1c at Week 72Baseline, Week 72
Change from Baseline in Fasting GlucoseBaseline up to 72 weeks
Percentage of Participants Achieving HbA1c of <7.0%Baseline up to 72 weeks
Percentage of Participants Achieving Weight Reduction of ≥5%Baseline up to 72 weeks
Change from Baseline in Waist CircumferenceBaseline up to 72 weeks
Change from Baseline in Body Max Index (BMI)Baseline, Week 72
Change from Baseline in Systolic Blood Pressure (SBP)Baseline up to 72 weeks
Percent Change from Baseline in TriglyceridesBaseline up to 72 weeks
Change from Baseline in EQ-5D-5LBaseline, Week 72
Pharmacokinetics (PK): Steady State Area Under the Concentration Time Curve (AUC-ss) of OrforglipronPredose through Week 48

Trial Locations

Locations (89)

Southern California Clinical Research

🇺🇸

Santa Ana, California, United States

Novak Clinical Research - Tucson - North La Cholla Boulevard

🇺🇸

Tucson, Arizona, United States

Norcal Endocrinology & Internal Medicine

🇺🇸

San Ramon, California, United States

Care Access - Thousand Oaks

🇺🇸

Thousand Oaks, California, United States

Accel Research Sites - DeLand Clinical Research Unit

🇺🇸

DeLand, Florida, United States

Innovation Medical Research Center - Fort Lauderdale

🇺🇸

Fort Lauderdale, Florida, United States

Encore Medical Research

🇺🇸

Hollywood, Florida, United States

West Orange Endocrinology P.A.

🇺🇸

Ocoee, Florida, United States

Care Access - Tampa

🇺🇸

Tampa, Florida, United States

Care Access - Decatur

🇺🇸

Decatur, Georgia, United States

Accel Research Sites - NeuroStudies Clinical Research Unit

🇺🇸

Decatur, Georgia, United States

Javara - Privia Medical Group Georgia - Savannah

🇺🇸

Savannah, Georgia, United States

North Georgia Clinical Research

🇺🇸

Woodstock, Georgia, United States

Solaris Clinical Research

🇺🇸

Meridian, Idaho, United States

Care Access - New Iberia

🇺🇸

New Iberia, Louisiana, United States

Endocrine and Metabolic Consultants

🇺🇸

Rockville, Maryland, United States

Javara - Privia Medical Group - Silver Spring

🇺🇸

Silver Spring, Maryland, United States

Boeson Research MSO

🇺🇸

Missoula, Montana, United States

Javara - Nevada Health Centers - Carson City

🇺🇸

Carson City, Nevada, United States

The Machuca Foundation

🇺🇸

Las Vegas, Nevada, United States

University of North Carolina Medical Center

🇺🇸

Chapel Hill, North Carolina, United States

Javara - Tryon Medical Partners

🇺🇸

Charlotte, North Carolina, United States

Care Access - Fayetteville

🇺🇸

Fayetteville, North Carolina, United States

The Corvallis Clinic, P.C.

🇺🇸

Corvallis, Oregon, United States

CARE - Centro de Alergia y Enfermedades Respiratorias

🇦🇷

Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

Centro Médico Viamonte

🇦🇷

Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina

Clinical Research of Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

Frontier Clinical Research, LLC

🇺🇸

Smithfield, Pennsylvania, United States

Velocity Clinical Research, Dallas

🇺🇸

Dallas, Texas, United States

Biopharma Informatic, LLC

🇺🇸

Houston, Texas, United States

Zhujiang Hospital

🇨🇳

Guangzhou, Guangdong, China

Texas Valley Clinical Research (TVCR) - Mission

🇺🇸

Mission, Texas, United States

Consano Clinical Research, LLC

🇺🇸

Shavano Park, Texas, United States

CIPREC

🇦🇷

Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina

Instituto Centenario

🇦🇷

Caba, Ciudad Autónoma De Buenos Aires, Argentina

Instituto Médico Catamarca IMEC

🇦🇷

Rosario, Santa Fe, Argentina

Centro de Diagnóstico y Rehabilitación (CEDIR)

🇦🇷

Santa Fe, Argentina

The Second People's Hospital of Hefei

🇨🇳

Hefei, Anhui, China

Peking University Third Hospital

🇨🇳

Beijing, Beijing, China

The Second Affiliated Hospital of Nanjing Medical University

🇨🇳

Nanjing, Jiangsu, China

Xuanwu Hospital Capital Medical University

🇨🇳

Beijing, Beijing, China

The First Affiliated Hospital of Henan University of Science &Technology

🇨🇳

Luoyang Shi, Henan, China

Zhongda Hospital Southeast University

🇨🇳

Nanjing, Jiangsu, China

The Second Affiliated Hospital Chongqing Medical University

🇨🇳

Chongqing, Chongqing, China

The Fourth Affiliated Hospital of Harbin Medical University

🇨🇳

Harbin, Heilongjiang, China

Jinan Central Hospital

🇨🇳

Jinan, Shandong, China

Sichuan Provincial People's Hospital

🇨🇳

Chengdu, Sichuan, China

The Second Hospital of Tianjin Medical University

🇨🇳

Tianjin, Tianjin, China

MUDr. Alena Vachova

🇨🇿

Ceske Budejovice, Jihočeský Kraj, Czechia

VASOMED Clinic

🇨🇿

Ostrava, Moravskoslezský Kraj, Czechia

Milan Kvapil s.r.o., Diabetologicka ambulance

🇨🇿

Praha, Praha 4, Czechia

Medical Plus

🇨🇿

Uherske Hradiste, Zlínský Kraj, Czechia

Nemocnice Cesky Krumlov

🇨🇿

Český Krumlov, Czechia

Medicover Neuroendokrinologie

🇩🇪

Munich, Bayern, Germany

InnoDiab Forschung Gmbh

🇩🇪

Essen, Nordrhein-Westfalen, Germany

Medizentrum Essen Borbeck

🇩🇪

Essen, Nordrhein-Westfalen, Germany

AmBeNet GmbH

🇩🇪

Leipzig, Sachsen, Germany

Gemeinschaftspraxis Dr. Taeschner/Dr. Bonigut

🇩🇪

Leipzig, Sachsen, Germany

RED-Institut GmbH

🇩🇪

Oldenburg, Schleswig-Holstein, Germany

Diabetes Zentrum Wilhelmsburg

🇩🇪

Hamburg, Germany

Apollo Excelcare Hospital

🇮🇳

Guwahati, Assam, India

Sir Ganga Ram Hospital

🇮🇳

New Delhi, Delhi, India

Karnataka Institute of Medical Sciences

🇮🇳

Hubli, Karnataka, India

Chellaram Diabetes Institute

🇮🇳

Pune, Maharashtra, India

All India Institute of Medical Sciences

🇮🇳

Bhubaneswar, Odisha, India

Diabetes Research Center

🇮🇳

Hyderabad, Telangana, India

All India Institute of Medical Sciences - Rishikesh

🇮🇳

Rishikesh, Uttarakhand, India

Tokuyama Clinic

🇯🇵

Mihama-ku,Chiba City, Chiba, Japan

Hasegawa Medical Clinic

🇯🇵

Chitose, Hokkaido, Japan

Tsuchiura Medical & Health Care Center

🇯🇵

Tsuchiura, Ibaraki, Japan

Noritake Clinic

🇯🇵

Ushiku, Ibaraki, Japan

Olive Takamatsu Medical Clinic

🇯🇵

Takamatsu, Kagawa, Japan

Medical Corporation Yuga Tsuruma Kaneshiro Diabetes Clinic

🇯🇵

Yamato-shi, Kanagawa, Japan

Yokohama Minoru Clinic

🇯🇵

Yokohama, Kanagawa, Japan

Medical Corporation Heishinkai OCROM Clinic

🇯🇵

Suita-shi, Osaka, Japan

The Institute of Medical Science, Asahi Life Foundation

🇯🇵

Chuo-ku, Tokyo, Japan

Tokyo-Eki Center-building Clinic

🇯🇵

Chuo-ku, Tokyo, Japan

Fukuwa Clinic

🇯🇵

Chuo-ku, Tokyo, Japan

Medical Corporation Heishinkai ToCROM Clinic

🇯🇵

Shinjuku-ku, Tokyo, Japan

Shimokitazawa Tomo Clinic

🇯🇵

Tokyo, Japan

RM Pharma Specialists - Unidad Especializada en Datos

🇲🇽

Mexico City, Distrito Federal, Mexico

Endocrinologia Especializada

🇲🇽

Mexico, Distrito Federal, Mexico

Diseno y Planeacion en Investigacion Medica - Guadalajara - Calle Amado Nervo

🇲🇽

Guadalajara, Jalisco, Mexico

Centro Medico Zambrano Hellion

🇲🇽

San Pedro Garza Garcia, Nuevo León, Mexico

Medical Care and Research SA de CV

🇲🇽

Merida, Yucatán, Mexico

Kohler & Milstein Research S.A. De C.V.

🇲🇽

Mérida, Yucatán, Mexico

Enclifar Ensayos Clínicos Farmacológicos Sc

🇲🇽

Chihuahua, Mexico

Puerto Rico Health and Wellness Institute

🇵🇷

Dorado, Puerto Rico

Isis Clinical Research Center

🇵🇷

Guaynabo, Puerto Rico

© Copyright 2025. All Rights Reserved by MedPath